Last updated on November 2019

A Study to Evaluate the Safety and Efficacy of CRN00808 for the Treatment of Acromegaly


Brief description of study

An open label exploratory study designed to evaluate the safety, efficacy, and pharmacokinetics of CRN00808 (an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly that are treated with somatostatin analogue (SSA) based treatment regimens.

Clinical Study Identifier: NCT03789656

Find a site near you

Start Over